A-1 (CAPRA HIRCUS SKIN, FELIS CATUS SKIN, BOS TAURUS SKIN, CANIS LUPUS FAMILIARIS SKIN, EQUUS CABALLUS SKIN, CAPRA HIRCUS HAIR, and Sheep Wool)
**Product type:** Human Otc Drug
**Active ingredient:** BOS TAURUS SKIN; CANIS LUPUS FAMILIARIS SKIN; CAPRA HIRCUS HAIR; CAPRA HIRCUS SKIN; EQUUS CABALLUS SKIN; FELIS CATUS SKIN; SHEEP WOOL
**Strength:** 30; 30; 30; 30; 30; 30; 30 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
**Dosage form:** Solution
**Route:** Sublingual
**Labeler:** DNA Labs, Inc.
**Marketing category:** UNAPPROVED HOMEOPATHIC
**Pharmacologic class:** Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Animal Fur [CS], Animal Fur [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Cells, Epidermal [EXT], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Animal Hair Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Non-Standardized Animal Skin Allergenic Extract [EPC], Standardized Animal Skin Allergenic Extract [EPC]
/api/v1/systems/ndc_fda/nodes/58264-0293Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.